This topic contains a solution. Click here to go to the answer

Author Question: The action of tetanospasmin, the toxin responsible for tetanus, interferes with the a. production ... (Read 35 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
The action of tetanospasmin, the toxin responsible for tetanus, interferes with the
 
  a. production of action potentials.
  b. production of EPSPs.
 c. production of IPSPs.
 d. presynaptic facilitation.

Question 2

The neurotoxin tetanospasmin, which produces the condition tetanus, invades the central nervous system by
 
  a. passing through the blood brain barrier.
 b. traveling via anterograde transport outside of neurons.
 c. traveling via retrograde transport within axons.
 d. traveling via retrograde transport between synapses.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

c

Answer to Question 2

c




james9437

  • Member
  • Posts: 568
Reply 2 on: Jun 21, 2018
Excellent


scottmt

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library